Industry Research Reports
Home > Reports > Chemical & Material > Global Plant-Based Antimicrobial Formulations Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Plant-Based Antimicrobial Formulations Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 127 Pages
Report ld: 4877688
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Plant-Based Antimicrobial Formulations market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
From a downstream perspective, Food accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Plant-Based Antimicrobial Formulations leading manufacturers including HeiQ Materials AG, Proneem, Prinova Group, etc., dominate supply; the top five capture approximately % of global revenue, with HeiQ Materials AG leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Plant-Based Antimicrobial Formulations market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- HeiQ Materials AG
- Proneem
- Prinova Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Liquid
- Powder
- Other
Segment by Application
- Food
- Coatings
- Textiles
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Plant-Based Antimicrobial Formulations study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Plant-Based Antimicrobial Formulations: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Plant-Based Antimicrobial Formulations Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liquid
1.2.3 Powder
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Plant-Based Antimicrobial Formulations Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food
1.3.3 Coatings
1.3.4 Textiles
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plant-Based Antimicrobial Formulations Revenue Estimates and Forecasts 2020-2031
2.2 Global Plant-Based Antimicrobial Formulations Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Plant-Based Antimicrobial Formulations Sales Estimates and Forecasts 2020-2031
2.4 Global Plant-Based Antimicrobial Formulations Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Plant-Based Antimicrobial Formulations Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Plant-Based Antimicrobial Formulations Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Plant-Based Antimicrobial Formulations Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Liquid Market Size by Manufacturers
4.5.2 Powder Market Size by Manufacturers
4.5.3 Other Market Size by Manufacturers
4.6 Global Plant-Based Antimicrobial Formulations Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Plant-Based Antimicrobial Formulations Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Plant-Based Antimicrobial Formulations Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Plant-Based Antimicrobial Formulations Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Plant-Based Antimicrobial Formulations Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Plant-Based Antimicrobial Formulations Sales and Revenue by Type (2020-2031)
7.4 North America Plant-Based Antimicrobial Formulations Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Plant-Based Antimicrobial Formulations Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Plant-Based Antimicrobial Formulations Sales and Revenue by Type (2020-2031)
8.4 Europe Plant-Based Antimicrobial Formulations Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Plant-Based Antimicrobial Formulations Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Plant-Based Antimicrobial Formulations Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Plant-Based Antimicrobial Formulations Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Plant-Based Antimicrobial Formulations Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Plant-Based Antimicrobial Formulations Sales and Revenue by Type (2020-2031)
10.4 Central and South America Plant-Based Antimicrobial Formulations Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Plant-Based Antimicrobial Formulations Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Plant-Based Antimicrobial Formulations Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Plant-Based Antimicrobial Formulations Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Plant-Based Antimicrobial Formulations Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 HeiQ Materials AG
12.1.1 HeiQ Materials AG Corporation Information
12.1.2 HeiQ Materials AG Business Overview
12.1.3 HeiQ Materials AG Plant-Based Antimicrobial Formulations Product Models, Descriptions and Specifications
12.1.4 HeiQ Materials AG Plant-Based Antimicrobial Formulations Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 HeiQ Materials AG Plant-Based Antimicrobial Formulations Sales by Product in 2024
12.1.6 HeiQ Materials AG Plant-Based Antimicrobial Formulations Sales by Application in 2024
12.1.7 HeiQ Materials AG Plant-Based Antimicrobial Formulations Sales by Geographic Area in 2024
12.1.8 HeiQ Materials AG Plant-Based Antimicrobial Formulations SWOT Analysis
12.1.9 HeiQ Materials AG Recent Developments
12.2 Proneem
12.2.1 Proneem Corporation Information
12.2.2 Proneem Business Overview
12.2.3 Proneem Plant-Based Antimicrobial Formulations Product Models, Descriptions and Specifications
12.2.4 Proneem Plant-Based Antimicrobial Formulations Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Proneem Plant-Based Antimicrobial Formulations Sales by Product in 2024
12.2.6 Proneem Plant-Based Antimicrobial Formulations Sales by Application in 2024
12.2.7 Proneem Plant-Based Antimicrobial Formulations Sales by Geographic Area in 2024
12.2.8 Proneem Plant-Based Antimicrobial Formulations SWOT Analysis
12.2.9 Proneem Recent Developments
12.3 Prinova Group
12.3.1 Prinova Group Corporation Information
12.3.2 Prinova Group Business Overview
12.3.3 Prinova Group Plant-Based Antimicrobial Formulations Product Models, Descriptions and Specifications
12.3.4 Prinova Group Plant-Based Antimicrobial Formulations Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Prinova Group Plant-Based Antimicrobial Formulations Sales by Product in 2024
12.3.6 Prinova Group Plant-Based Antimicrobial Formulations Sales by Application in 2024
12.3.7 Prinova Group Plant-Based Antimicrobial Formulations Sales by Geographic Area in 2024
12.3.8 Prinova Group Plant-Based Antimicrobial Formulations SWOT Analysis
12.3.9 Prinova Group Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Plant-Based Antimicrobial Formulations Industry Chain
13.2 Plant-Based Antimicrobial Formulations Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Plant-Based Antimicrobial Formulations Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Plant-Based Antimicrobial Formulations Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Plant-Based Antimicrobial Formulations Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Plant-Based Antimicrobial Formulations Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Plant-Based Antimicrobial Formulations Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Plant-Based Antimicrobial Formulations Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Plant-Based Antimicrobial Formulations Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Plant-Based Antimicrobial Formulations Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Plant-Based Antimicrobial Formulations Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Plant-Based Antimicrobial Formulations Sales by Region (2020-2025) & (Tons)
Table 8. Global Plant-Based Antimicrobial Formulations Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Plant-Based Antimicrobial Formulations Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Plant-Based Antimicrobial Formulations Production by Region (2020-2025) & (Tons)
Table 12. Global Plant-Based Antimicrobial Formulations Production by Region (2026-2031) & (Tons)
Table 13. Global Plant-Based Antimicrobial Formulations Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Plant-Based Antimicrobial Formulations Sales Share by Manufacturers (2020-2025)
Table 15. Global Plant-Based Antimicrobial Formulations Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Plant-Based Antimicrobial Formulations Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Plant-Based Antimicrobial Formulations by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant-Based Antimicrobial Formulations as of 2024)
Table 19. Global Plant-Based Antimicrobial Formulations Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Plant-Based Antimicrobial Formulations Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Plant-Based Antimicrobial Formulations Manufacturing Base and Headquarters
Table 22. Global Plant-Based Antimicrobial Formulations Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Plant-Based Antimicrobial Formulations Sales by Type (2020-2025) & (Tons)
Table 26. Global Plant-Based Antimicrobial Formulations Sales by Type (2026-2031) & (Tons)
Table 27. Global Plant-Based Antimicrobial Formulations Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Plant-Based Antimicrobial Formulations Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Plant-Based Antimicrobial Formulations ASP by Type (2020-2031) & (US$/kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Plant-Based Antimicrobial Formulations Sales by Application (2020-2025) & (Tons)
Table 32. Global Plant-Based Antimicrobial Formulations Sales by Application (2026-2031) & (Tons)
Table 33. Plant-Based Antimicrobial Formulations High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Plant-Based Antimicrobial Formulations Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Plant-Based Antimicrobial Formulations Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Plant-Based Antimicrobial Formulations ASP by Application (2020-2031) & (US$/kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Plant-Based Antimicrobial Formulations Growth Accelerators and Market Barriers
Table 40. North America Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Plant-Based Antimicrobial Formulations Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Plant-Based Antimicrobial Formulations Growth Accelerators and Market Barriers
Table 43. Europe Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Plant-Based Antimicrobial Formulations Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Plant-Based Antimicrobial Formulations Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Plant-Based Antimicrobial Formulations Growth Accelerators and Market Barriers
Table 48. Southeast Asia Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Plant-Based Antimicrobial Formulations Investment Opportunities and Key Challenges
Table 50. Central and South America Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Plant-Based Antimicrobial Formulations Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Plant-Based Antimicrobial Formulations Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. HeiQ Materials AG Corporation Information
Table 54. HeiQ Materials AG Description and Major Businesses
Table 55. HeiQ Materials AG Product Models, Descriptions and Specifications
Table 56. HeiQ Materials AG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 57. HeiQ Materials AG Sales Value Proportion by Product in 2024
Table 58. HeiQ Materials AG Sales Value Proportion by Application in 2024
Table 59. HeiQ Materials AG Sales Value Proportion by Geographic Area in 2024
Table 60. HeiQ Materials AG Plant-Based Antimicrobial Formulations SWOT Analysis
Table 61. HeiQ Materials AG Recent Developments
Table 62. Proneem Corporation Information
Table 63. Proneem Description and Major Businesses
Table 64. Proneem Product Models, Descriptions and Specifications
Table 65. Proneem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 66. Proneem Sales Value Proportion by Product in 2024
Table 67. Proneem Sales Value Proportion by Application in 2024
Table 68. Proneem Sales Value Proportion by Geographic Area in 2024
Table 69. Proneem Plant-Based Antimicrobial Formulations SWOT Analysis
Table 70. Proneem Recent Developments
Table 71. Prinova Group Corporation Information
Table 72. Prinova Group Description and Major Businesses
Table 73. Prinova Group Product Models, Descriptions and Specifications
Table 74. Prinova Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Prinova Group Sales Value Proportion by Product in 2024
Table 76. Prinova Group Sales Value Proportion by Application in 2024
Table 77. Prinova Group Sales Value Proportion by Geographic Area in 2024
Table 78. Prinova Group Plant-Based Antimicrobial Formulations SWOT Analysis
Table 79. Prinova Group Recent Developments
Table 80. Key Raw Materials Distribution
Table 81. Raw Materials Key Suppliers
Table 82. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 83. Milestones in Production Technology Evolution
Table 84. Distributors List
Table 85. Market Trends and Market Evolution
Table 86. Market Drivers and Opportunities
Table 87. Market Challenges, Risks, and Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Plant-Based Antimicrobial Formulations Product Picture
Figure 2. Global Plant-Based Antimicrobial Formulations Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Other Product Picture
Figure 6. Global Plant-Based Antimicrobial Formulations Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Food
Figure 8. Coatings
Figure 9. Textiles
Figure 10. Other
Figure 11. Plant-Based Antimicrobial Formulations Report Years Considered
Figure 12. Global Plant-Based Antimicrobial Formulations Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 14. Global Plant-Based Antimicrobial Formulations Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Plant-Based Antimicrobial Formulations Revenue Market Share by Region (2020-2031)
Figure 16. Global Plant-Based Antimicrobial Formulations Sales (2020-2031) & (Tons)
Figure 17. Global Plant-Based Antimicrobial Formulations Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Plant-Based Antimicrobial Formulations Sales Market Share by Region (2020-2031)
Figure 19. Global Plant-Based Antimicrobial Formulations Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Plant-Based Antimicrobial Formulations Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Plant-Based Antimicrobial Formulations Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Plant-Based Antimicrobial Formulations Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Plant-Based Antimicrobial Formulations Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Plant-Based Antimicrobial Formulations Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Plant-Based Antimicrobial Formulations Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Plant-Based Antimicrobial Formulations Sales Volume Market Share in 2024
Figure 28. Global Plant-Based Antimicrobial Formulations Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Liquid Revenue Market Share by Manufacturer in 2024
Figure 31. Powder Revenue Market Share by Manufacturer in 2024
Figure 32. Other Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global Plant-Based Antimicrobial Formulations Sales Market Share by Type (2020-2031)
Figure 36. Global Plant-Based Antimicrobial Formulations Revenue Market Share by Type (2020-2031)
Figure 37. Global Plant-Based Antimicrobial Formulations Sales Market Share by Application (2020-2031)
Figure 38. Global Plant-Based Antimicrobial Formulations Revenue Market Share by Application (2020-2031)
Figure 39. North America Plant-Based Antimicrobial Formulations Sales YoY (2020-2031) & (Tons)
Figure 40. North America Plant-Based Antimicrobial Formulations Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) in 2024
Figure 42. North America Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Type (2020- 2031)
Figure 43. North America Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Application (2020-2031)
Figure 45. North America Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 47. Canada Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 49. Europe Plant-Based Antimicrobial Formulations Sales YoY (2020-2031) & (Tons)
Figure 50. Europe Plant-Based Antimicrobial Formulations Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) in 2024
Figure 52. Europe Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Type (2020-2031)
Figure 53. Europe Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Application (2020-2031)
Figure 55. Europe Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 57. France Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 59. Italy Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 60. Russia Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Plant-Based Antimicrobial Formulations Sales YoY (2020-2031) & (Tons)
Figure 62. Asia-Pacific Plant-Based Antimicrobial Formulations Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Type (2020- 2031)
Figure 65. Asia-Pacific Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Application (2020-2031)
Figure 67. Asia-Pacific Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 69. Japan Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 72. India Plant-Based Antimicrobial Formulations Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America Plant-Based Antimicrobial Formulations Sales YoY (2020-2031) & (Tons)
Figure 74. Central and South America Plant-Based Antimicrobial Formulations Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Type (2021-2031)
Figure 77. Central and South America Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Application (2020-2031)
Figure 79. Central and South America Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa Plant-Based Antimicrobial Formulations Sales YoY (2020-2031) & (Tons)
Figure 83. Middle East and Africa Plant-Based Antimicrobial Formulations Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Type (2021-2031)
Figure 86. South America Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa Plant-Based Antimicrobial Formulations Sales Volume (Tons) by Application (2020-2031)
Figure 88. Middle East and Africa Plant-Based Antimicrobial Formulations Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa Plant-Based Antimicrobial Formulations Revenue (2020-2025) & (US$ Million)
Figure 93. Plant-Based Antimicrobial Formulations Industry Chain Mapping
Figure 94. Regional Plant-Based Antimicrobial Formulations Manufacturing Base Distribution (%)
Figure 95. Plant-Based Antimicrobial Formulations Production Process
Figure 96. Regional Plant-Based Antimicrobial Formulations Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Plant-Based Antimicrobial Formulations market?
The top companies in the global Plant-Based Antimicrobial Formulations market are HeiQ Materials AG、Proneem、Prinova Group.
Related Reports
Global Plant-Based Antimicrobial Formulations Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plant-Based Antimicrobial Formulations market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 130
USD 4900.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Plant-Based Antimicrobial Formulations market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 69
USD 4250.00
(Single User License)
Plant-Based Antimicrobial Formulations- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plant-Based Antimicrobial Formulations was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 88
USD 3950.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Market Research Report 2026
The global Plant-Based Antimicrobial Formulations market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 121
USD 2900.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Plant-Based Antimicrobial Formulations market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 68
USD 4250.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Market Research Report 2025
The global market for Plant-Based Antimicrobial Formulations was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 79
USD 2900.00
(Single User License)
Plant-Based Antimicrobial Formulations - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Plant-Based Antimicrobial Formulations was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 88
USD 3950.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Market Research Report 2024
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published Date: 2024-07-31
Pages: 84
USD 2900.00
(Single User License)
Global and United States Plant-Based Antimicrobial Formulations Market Report & Forecast 2024-2030
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published Date: 2024-07-31
Pages: 88
USD 4350.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Market Insights, Forecast to 2030
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published Date: 2024-07-31
Pages: 115
USD 4900.00
(Single User License)
Global Plant-Based Antimicrobial Formulations Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Plant-Based Antimicrobial Formulations market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 130
USD 4900.00 (Single User License)Global Plant-Based Antimicrobial Formulations Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Plant-Based Antimicrobial Formulations market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 69
USD 4250.00 (Single User License)Plant-Based Antimicrobial Formulations- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Plant-Based Antimicrobial Formulations was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 88
USD 3950.00 (Single User License)Global Plant-Based Antimicrobial Formulations Market Research Report 2026
The global Plant-Based Antimicrobial Formulations market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 121
USD 2900.00 (Single User License)Global Plant-Based Antimicrobial Formulations Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Plant-Based Antimicrobial Formulations market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 68
USD 4250.00 (Single User License)Global Plant-Based Antimicrobial Formulations Market Research Report 2025
The global market for Plant-Based Antimicrobial Formulations was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 79
USD 2900.00 (Single User License)Plant-Based Antimicrobial Formulations - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Plant-Based Antimicrobial Formulations was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 88
USD 3950.00 (Single User License)Global Plant-Based Antimicrobial Formulations Market Research Report 2024
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published: 2024-07-31
Pages: 84
USD 2900.00 (Single User License)Global and United States Plant-Based Antimicrobial Formulations Market Report & Forecast 2024-2030
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published: 2024-07-31
Pages: 88
USD 4350.00 (Single User License)Global Plant-Based Antimicrobial Formulations Market Insights, Forecast to 2030
Plant-based antimicrobial formulations are natural compounds derived from plants that inhibit the growth of microorganisms. With the increasing consumer demand for natural and sustainable products, the market for these additives is expanding rapidly. These additives are used in various industries, including food, coatings, textiles to enhance product safety and shelf life.
Published: 2024-07-31
Pages: 115
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now